In order to test whether the administration of DJ-1 exerts cardioprotection after MI, a group of mice were intraperitoneal treated with human recombinant DJ-1 (50 μg) 1 h before LAD coronary artery ligation, in a double-blind experimental design, and heart samples were processed for histological analysis. This evidence concerns the gene PARK7 and myocardial infarction.